MSR
CVS icon

Main Street Research’s CVS Health CVS Stock Holding History

Main Street Research’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-223,180
Closed -$22.6M – 92
2022
Q1 		$22.6M Buy
+223,180
New +$23.4M 2.12% 27
2017
Q4 		– Sell
-2,724
Closed -$222K – 109
2017
Q3 		$222K Sell
2,724
-337
-11% -$26.7K 0.04% 104
2017
Q2 		$246K Sell
3,061
-40
-1% -$3.16K 0.04% 109
2017
Q1 		$243K Sell
3,101
-415
-12% -$33.1K 0.04% 103
2016
Q4 		$277K Sell
3,516
-300
-8% -$24.3K 0.05% 94
2016
Q3 		$340K Sell
3,816
-1,068
-22% -$101K 0.07% 87
2016
Q2 		$468K Buy
4,884
+493
+11% +$49.1K 0.1% 78
2016
Q1 		$455K Buy
4,391
+350
+9% +$34K 0.12% 69
2015
Q4 		$395K Hold
4,041
– – 0.08% 86
2015
Q3 		$399K Hold
4,041
– – 0.09% 86
2015
Q2 		$424K Buy
4,041
+200
+5% +$20.4K 0.09% 101
2015
Q1 		$396K Buy
3,841
+380
+11% +$38.5K 0.09% 102
2014
Q4 		$333K Buy
+3,461
New +$305K 0.07% 104
2014
Q3 		– Sell
-3,091
Closed -$233K – 135
2014
Q2 		$233K Hold
3,091
– – 0.05% 123
2014
Q1 		$231K Sell
3,091
-90
-3% -$6.36K 0.06% 130
2013
Q4 		$228K Buy
+3,181
New +$204K 0.06% 137

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Main Street Research's CVS Position: Q2 2022 in Review

Main Street Research sold out of CVS Health (CVS) in Q2 2022, closing a stake of 223,180 shares — an estimated $22.6M sold.

Main Street Research first reported a position in CVS in Q4 2013 and held it in 16 quarters. The position peaked at $22.6M in Q1 2022. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Main Street Research reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
  • Main Street Research sold 223,180 CVS Health shares in Q2 2022, an estimated $22.6M.
  • Main Street Research first reported a position in CVS Health in Q4 2013 and held it in 16 quarters.
  • Main Street Research's CVS Health position peaked at $22.6M in Q1 2022.
  • 2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Main Street Research's 13F filing for Q2 2022, filed 12 Aug 2022.